TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer

Colon cancer is the third most important cancer type, leading to a remarkable number of deaths, indicating the necessity of new biomarkers and therapeutic targets for colon cancer patients. Several transmembrane proteins (TMEMs) are associated with tumor progression and cancer malignancy. However, the clinical significance and biological roles of TMEM211 in cancer, especially in colon cancer, are still unknown. In this study, we found that TMEM211 was highly expressed in tumor tissues and the increased TMEM211 was associated with poor prognosis in colon cancer patients from The Cancer Genome Atlas (TCGA) database. We also showed that abilities regarding migration and invasion were reduced in TMEM211-silenced colon cancer cells (HCT116 and DLD-1). Moreover, TMEM211-silenced colon cancer cells showed decreased levels of Twist1, N-cadherin, Snail and Slug but increased levels of E-cadherin. Levels of phosphorylated ERK, AKT and RelA (NF-κB p65) were also decreased in TMEM211-silenced colon cancer cells. Our findings indicate that TMEM211 regulates epithelial–mesenchymal transition for metastasis through coactivating the ERK, AKT and NF-κB signaling pathways, which might provide a potential prognostic biomarker or therapeutic target for colon cancer patients in the future.

[1]  W. Leowattana,et al.  Systemic treatment for metastatic colorectal cancer , 2023, World journal of gastroenterology.

[2]  M. Boerries,et al.  Non-canonical functions of SNAIL drive context-specific cancer progression , 2023, Nature Communications.

[3]  A. Jemal,et al.  Colorectal cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[4]  Michael R Hamblin,et al.  Cancer stem cells in colorectal cancer: signaling pathways involved in stemness and therapy resistance. , 2023, Critical reviews in oncology/hematology.

[5]  F. Marincola,et al.  Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer , 2023, Cancers.

[6]  I. Mackenzie,et al.  Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging , 2022, Acta Neuropathologica.

[7]  Jia Cao,et al.  TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway , 2022, Journal of Cancer Research and Clinical Oncology.

[8]  T. Salo,et al.  TWIST1 Regulates Proliferation, Migration and Invasion and is a Prognostic Marker for Oral Tongue Squamous Cell Carcinoma. , 2022, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  Xiaohong Wang,et al.  TMEM14A aggravates the progression of human ovarian cancer cells by enhancing the activity of glycolysis , 2022, Experimental and therapeutic medicine.

[10]  Md. Jamal Hossain,et al.  A Renewed Concept on the MAPK Signaling Pathway in Cancers: Polyphenols as a Choice of Therapeutics. , 2022, Pharmacological research.

[11]  Ronglin Wang,et al.  TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis , 2022, Cellular & Molecular Biology Letters.

[12]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[13]  E. Pogatzki-Zahn,et al.  Tmem160 contributes to the establishment of discrete nerve injury-induced pain behaviors in male mice. , 2021, Cell reports.

[14]  Runming Wang,et al.  TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway , 2021, Cell Death & Disease.

[15]  L. Ger,et al.  Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma , 2021, International journal of molecular sciences.

[16]  Oliwia Koteluk,et al.  The Landscape of Transmembrane Protein Family Members in Head and Neck Cancers: Their Biological Role and Diagnostic Utility , 2021, Cancers.

[17]  L. Ger,et al.  Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma , 2021, Cancers.

[18]  D. Xie,et al.  TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway , 2021, Oncology reports.

[19]  K. Yamaguchi,et al.  BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer , 2021, Molecular and Cellular Biochemistry.

[20]  M. Kojima,et al.  High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer , 2021, BMC cancer.

[21]  Fangfang Bi,et al.  TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway , 2021, Journal of translational medicine.

[22]  Xiao-hui Fu,et al.  TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma , 2021, Aging.

[23]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[24]  K. Mortezaee,et al.  Steps in metastasis: an updated review , 2021, Medical Oncology.

[25]  M. Greabu,et al.  PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects , 2020, International journal of molecular sciences.

[26]  Yuanyu Wu,et al.  Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon Cancer. , 2020, DNA and cell biology.

[27]  O. Witkowska-Piłaszewicz,et al.  Role of Cadherins in Cancer—A Review , 2020, International journal of molecular sciences.

[28]  R. Kreutz,et al.  Tmem63c is a potential pro-survival factor in angiotensin II-treated human podocytes. , 2020, Life sciences.

[29]  E. Sterneck,et al.  Slug and E-Cadherin: Stealth Accomplices? , 2020, Frontiers in Molecular Biosciences.

[30]  Shuang Liu,et al.  TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. , 2020, Discovery medicine.

[31]  A. Cabassi,et al.  Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis. , 2020, Journal of hypertension.

[32]  J. Wouters,et al.  Transmembrane (TMEM) protein family members: poorly characterized even if essential for the metastatic process. , 2020, Seminars in cancer biology.

[33]  J. Rutka,et al.  Role of Cl- channels in primary brain tumour. , 2019, Cell calcium.

[34]  L. Bhatt,et al.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer , 2019, Cancer biology & therapy.

[35]  A. Stepan,et al.  Immunoexpression of Snail, Twist1 and Slug in clear cell renal cell carcinoma. , 2019, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[36]  C. Michiels,et al.  TMEM Proteins in Cancer: A Review , 2018, Front. Pharmacol..

[37]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.

[38]  E. Wang,et al.  TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling , 2018, Cancer management and research.

[39]  Mintu Pal,et al.  Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis , 2018, Experimental cell research.

[40]  Mohini Singh,et al.  EMT: Mechanisms and therapeutic implications , 2017, Pharmacology & therapeutics.

[41]  V. Odero-Marah,et al.  Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer. , 2018, Advances in experimental medicine and biology.

[42]  A. Nitta,et al.  Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit , 2017, PloS one.

[43]  J. Gumin,et al.  TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression , 2017, Oncogene.

[44]  A. Mencalha,et al.  NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells , 2017, PloS one.

[45]  S. Kjaer,et al.  TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions. , 2016, American journal of cancer research.

[46]  Rong-cheng Luo,et al.  TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling , 2015, Oncotarget.

[47]  T. Ma,et al.  Inhibition of TMEM16A Expression Suppresses Growth and Invasion in Human Colorectal Cancer Cells , 2014, PloS one.

[48]  August G. Wang,et al.  Are TMEM genes potential candidate genes for panic disorder? , 2014, Psychiatric genetics.

[49]  G. Radice.  N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice. , 2013, Progress in molecular biology and translational science.

[50]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[51]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[52]  Xavier Matias-Guiu,et al.  NF-kB in development and progression of human cancer , 2005, Virchows Archiv.